Neuroreparation and advanced therapies
Head of program: Dr. Joan Vidal
Researchers: Dr. Jesús Benito, Dr. Gerardo Conesa, Dr. Guillermo García, Dr. Hatice Kumru, Dr. Xavier Navarro
Position our Institute as a national and international reference center for clinical phases of translational research in clinical trials, advanced therapies and regenerative medicine applied to spinal cord injury (SCI) and acquired brain damage (ACD).
- Promote the development of clinical trials in neuroregenerative operations.
- Develop multimodal neuromodulation strategies combined with intensive robot-assisted training.
- Develop a biodatabase of information derived from typification of patients at clinical (functional and structural) and subclinical level (neurophysiological and structural, through structural and functional and genetic neuroimaging) that serves for selection of candidates for this type of study.
NISCI - Multicenter, multinational, placebo controlled phase II study for the safety and preliminary efficacy of intrathecal ATI355 in patients with acute cervical spinal cord injury.
Project typology: European Competitive
CERMOD-ERANet-Neuron. Non-invasive electrical stimulation of the cervical spinal cord to facilitate arm and hand functional recovery in incomplete traumatic cervical spinal cord injured patients.
RED TERCEL - Cell therapy network.
Recovery of arm and hand movements in patients with cervical spinal cord injury through spinal electrical neuromodulation assisted with an arm exoskeleton.
Project typology: National, Competitive NGO
Randomized, double-blind, two-dose, placebo-controlled clinical safety study in the treatment of incomplete spinal cord injury at the cervical level with intrathecal WJ-MSC in multiple infusion